Literature DB >> 10589751

Classification and regression tree analysis of 1000 consecutive patients with unknown primary carcinoma.

K R Hess1, M C Abbruzzese, R Lenzi, M N Raber, J L Abbruzzese.   

Abstract

The clinical features and survival times of patients with unknown primary carcinoma (UPC) are heterogeneous. Therefore, the goals of this study were to apply a novel analytical method to UPC patients to: (a) identify novel prognostic factors; (b) explore the interactions between clinical variables and their impact on survival; and (c) illustrate explicitly how the covariates interact. The 1000 patients analyzed were referred to the University of Texas M. D. Anderson Cancer Center from January 1, 1987 through November 30, 1994. Clinical data from these patients were entered into a computerized database for storage, retrieval, and analysis. Multivariate analyses of survival were performed using recursive partitioning referred to as classification and regression tree (CART) analysis. The median survival for all 1000 consecutive UPC patients was 11 months. CART was performed with an initial split on liver involvement, and 10 terminal subgroups were formed. Median survival of the 10 subgroups ranged from 40 months (95% confidence interval, 22-66 months) for UPC patients with one or two metastatic organ sites, with nonadenocarcinoma histology, and without liver, bone, adrenal, or pleural metastases to 5 months (95% confidence interval, 4-7 months) in UPC patients with liver metastases, tumor histologies other than neuroendocrine carcinoma, age >61.5 years, and a small subgroup of patients with adrenal metastases. Two additional trees were also explored. These analyses demonstrated that important prognostic variables were consistently applied by the CART program and effectively segregated patients into groups with similar clinical features and survival. CART also identified previously unappreciated patient subsets and is a useful method for dissecting complex clinical situations and identifying homogeneous patient populations for future clinical trials.

Entities:  

Mesh:

Year:  1999        PMID: 10589751

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  51 in total

1.  Cytogenetic profile of unknown primary tumors: clues for their pathogenesis and clinical management.

Authors:  Dimitra Pantou; Haroula Tsarouha; Anna Papadopoulou; Louiza Mahaira; Ioannis Kyriazoglou; Nikiforos Apostolikas; Sophia Markidou; Theoni Trangas; Nikos Pandis; Georgia Bardi
Journal:  Neoplasia       Date:  2003 Jan-Feb       Impact factor: 5.715

Review 2.  Progress in refining the clinical management of cancer of unknown primary in the molecular era.

Authors:  Elie Rassy; Nicholas Pavlidis
Journal:  Nat Rev Clin Oncol       Date:  2020-04-29       Impact factor: 66.675

3.  Metastatic chest wall tumor suspected to be of lung origin by immunoreactivity for cytokeratin 7 and 20.

Authors:  Shuji Haraguchi; Masafumi Hioki; Mina Takushima; Kunio Yanagimoto; Kiyoshi Koizumi; Kazuo Shimizu
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-03

4.  Tumor-marker analysis and verification of prognostic models in patients with cancer of unknown primary, receiving platinum-based combination chemotherapy.

Authors:  Kan Yonemori; Masashi Ando; Taro Shibata; Noriyuki Katsumata; Koji Matsumoto; Yasuhiro Yamanaka; Tsutomu Kouno; Chikako Shimizu; Yasuhiro Fujiwara
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-22       Impact factor: 4.553

5.  Prognostic and diagnostic accuracy of [18F]FDG-PET/CT in 190 patients with carcinoma of unknown primary.

Authors:  Pavel Fencl; Otakar Belohlavek; Magdalena Skopalova; Monika Jaruskova; Iva Kantorova; Katerina Simonova
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06-01       Impact factor: 9.236

Review 6.  Applications of artificial intelligence systems in the analysis of epidemiological data.

Authors:  Andreas D Flouris; Jack Duffy
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

7.  An introduction to tree-structured modeling with application to quality of life data.

Authors:  Xiaogang Su; Andres Azuero; June Cho; Elizabeth Kvale; Karen M Meneses; M Patrick McNees
Journal:  Nurs Res       Date:  2011 Jul-Aug       Impact factor: 2.381

Review 8.  Carcinoma of unknown primary with hepatic metastases: a need of judicious and contemplative diagnostic algorithm.

Authors:  Vikram Sai Shivaji; Joseph Charles Wilson; Noemi L Schmidt; Orpheus Kolokythas; Neeraj Lalwani
Journal:  Abdom Radiol (NY)       Date:  2020-07-06

9.  Unfavorable cancers of unknown primaries: presentation and prognostic factors. A population-based 8-year experience.

Authors:  Margareta Randén; Maria Helde-Frankling; Sara Runesdotter; Peter Gunvén
Journal:  Med Oncol       Date:  2013-09-18       Impact factor: 3.064

10.  Metastases in the Absence of a Primary Tumor: Advances in the Diagnosis and Treatment of CUP Syndrome.

Authors:  Kai Neben; Gerdt Hübner; Gunnar Folprecht; Dirk Jäger; Alwin Krämer
Journal:  Dtsch Arztebl Int       Date:  2008-10-24       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.